Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned an average rating of “Hold” from the nineteen brokerages that are presently covering the firm, MarketBeat.com reports. Twelve investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $9.71.

Several equities research analysts have issued reports on TDOC shares. Bank of America cut their target price on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a research note on Friday, April 11th. Citigroup cut their price objective on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating for the company in a research report on Friday, April 25th. Jefferies Financial Group reduced their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, April 21st. Evercore ISI lowered their target price on shares of Teladoc Health from $8.00 to $7.00 and set an “in-line” rating for the company in a research note on Thursday, May 1st. Finally, Oppenheimer dropped their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th.

Teladoc Health Price Performance

Teladoc Health stock opened at $7.62 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $7.68 and a 200 day moving average price of $9.40. Teladoc Health has a 12-month low of $6.35 and a 12-month high of $15.21. The stock has a market cap of $1.34 billion, a P/E ratio of -1.32 and a beta of 1.82.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.58% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

Hedge funds have recently bought and sold shares of the stock. Golden State Wealth Management LLC grew its position in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock worth $27,000 after buying an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its holdings in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,581 shares in the last quarter. Versant Capital Management Inc increased its position in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health in the 4th quarter valued at $29,000. Finally, Lindbrook Capital LLC lifted its position in shares of Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after purchasing an additional 1,612 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.